Necessity of inositol (1,4,5)-trisphosphate receptor 1 and μ-calpain in NO-induced osteoclast motility

Journal of Cell Science

Volumn 120, Issue 16, 2007, Pages 2884-2894

  Yaroslavskiy, Beatrice B ^a   Sharrow, Allison C ^a   Wells, Alan ^a   Robinson, Lisa J ^a   Blair, Harry C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CAPN1; cGMP dependent protein kinase 1; Cyclic GMP; Inositol (1,4,5) trisphosphate; Nitric oxide; VASP

Indexed keywords

CALPAIN; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE 1; ESTROGEN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; NITRIC OXIDE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ARTICLE; CALCIUM SIGNALING; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PRIORITY JOURNAL; RNA INTERFERENCE; STRETCHING;

CALCIUM; CALCIUM SIGNALING; CALPAIN; CELL ADHESION MOLECULES; CELL MOVEMENT; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MICROFILAMENT PROTEINS; NITRIC OXIDE; OSTEOCLASTS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS PP60(C-SRC);

EID: 34548598258     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.004184     Document Type: Article

References (50)

1. Armour, K. E., Armour, K. J., Gallagher, M. E., Godecke, A., Helfrich, M. H., Reid, D. M. and Ralston, S. H. (2001). Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology 142, 760-766.
2. Armour, K. J., van't Hof, R. J., Armour, K. E., Torbergsen, A. C., Del Soldato, P. and Ralston, S. H. (2001). Inhibition of bone resorption in vitro and prevention of ovariectomy-induced bone loss in vivo by flurbiprofen niuroxybutylester (HCT1026). Arthritis Rheum. 44, 2185-2192.
3. Baki, A., Tompa, P., Alexa, A., Molnar, O. and Friedrich, P. (1996). Autolysis parallels activation of μ-calpain. Biochem. J. 318, 897-901.
4. Balla, T. (2006). Phosphoinositide-derived messengers in endocrine signaling. J. Endocrinol. 188, 135-153.
5. 2+-ATPase in osteoclast plasma membrane. J. Bone Miner Res. 5, 557-567.
6. Calle, Y., Carragher, N. O., Thrasher, A. J. and Jones, G. E. (2006). Inhibition of calpain stabilises podosomes and impairs dendritic cell motility. J. Cell Sci. 119, 2375-2385.
7. Cui, J., Matkovich, S. J., deSouza, N., Li, S., Rosemblit, N. and Marks, A. R. (2004). Regulation of the type 1 inositol 1,4,5-trisphosphate receptor by phosphorylation at Lyrosine 353. J. Biol. Chem. 279, 16311-16316.
8. Dedieu, S., Poussard, S., Mazeres, G., Grise, F., Dargelos, E, Cottin, P. and Brustis, J. J. (2004). Myoblast migration is regulated by calpain through its involvement in cell attachment and cytoskeletal organization. Exp. Cell Res. 292, 187-200.
9. Faccio, R., Novack, D. V., Zallone, A., Ross, F. P. and Teitelbaum, S. L. (2003). Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by β3 integrin. J. Cell Biol. 162, 499-509.
10. Falsafi, R., Tatakis, D. N., Hagel-Bradway, S. and Dziak, R. (1991). Effects of inositol trisphosphate on calcium mobilization in bone cells. Calcif. Tissue Int. 49, 333-339.
11. Ferris, C. D., Cameron, A. M., Huganir, R. L. and Snyder, S. H. (1992). Quantal calcium release by purified reconstituted inositol 1,4,5-trisphosphate receptors. Nature 356, 350-352.
12. Fritsch, R. M., Saur, D., Kurjak, M., Oesterle, D, Schlossmann, J., Geiselhoringer, A., Hofmann, F. and Allescher, H. D. (2004). InsP3R-associated cGMP kinase substrate (IRAG) is essential for nitric oxide-induced inhibition of calcium signaling in human colonic smooth muscle. J. Biol. Chem. 279, 12551-12559.
13. García Palacios, V., Robinson, L. J., Borysenko, C. W., Kalla, S.E. and Blair, H. C. (2005). Negative regulation of RANKL induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens. J. Biol. Chem. 280, 13720-13727.
14. Glading, A., Chang, P., Lauffenburger, D. A. and Wells, A. (2000). Epidermal growth factor receptor activation of calpain is required for fibroblast motility and occurs via an ERK/MAP kinase signaling pathway. J. Biol. Chem. 275, 2390-2398.
15. Glading, A., Bodnar, R. J., Reynolds, L. J., Shiraha, H., Satish, L., Potter, D. A., Blair, H. C. and Wells, A. (2004). Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol. Cell. Biol. 24, 2499-2512.
16. Golden, L. H. and Insogna, K. L. (2004). The expanding role of P13-kinase in bone. Bone 34, 3-12.
17. Grey, A., Chen, Y., Paliwal, I., Carlberg, K. and Insogna, K. (2000). Evidence for a functional association between phosphatidylinositol 3-kinase and c-src in the spreading response of osteoclasts to colony-stimulating factor-1. Endocrinology 141, 2129-2138.
18. 2+ release in guinea-pig hepatocytes. Biochem. J. 318, 849-855.
19. Hayashi, M., Koshihara, Y., Ishibashi, H., Yamamoto, S., Tsubuki, S., Saido, T. C., Kawashima, S. and Inomata, M. (2005). Involvement of calpain in ostecclastic bone resorption. J. Biochem. 137, 331-338.
20. 2+ entry mechanism. J. Biol. Chem. 275, 16242-16250.
21. Kasten, T. P., Collin-Osdoby, P., Patel, N., Osdoby, P., Krukowski, M., Misko, T. P., Settle, S. L., Currie, M. G. and Nickols, G. A. (1994). Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc. Natl. Acad. Sci. USA 91, 3569-35673.
22. Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E., Iwata, T., Ohnishi, H., Matozaki, T., Kodama, Y. et al. (2004). Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428, 758-763.
23. Komarova, S. V., Pereverzev, A., Shum, J. W., Sims, S. M. and Dixon, S. J. (2005). Convergent signaling by acidosis and receptor activator of NF-κB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts. Proc. Natl. Acad. Sci. USA 102, 2643-2648.
24. Lee, F. Y., Kim, D. W., Karmin, J. A., Hong, D., Chang, S. S., Fujisawa, M., Takayanagi, H., Bigliani, L. U., Blaine, T. A. and Lee, H. J. (2005). μ-Calpain regulates receptor activator of NF-κB ligand (RANKL)-supported osteoclastogenesis via NF-κB activation in RAW 264. 7 cells. J. Biol. Chem. 280, 29929-29936.
25. Marcantoni, A., Levi, R. C., Gallo, M. P., Hirsch, E. and Alloatti, G. (2006). Phosphoinositide 3-kinaseγ (P13Kγ) controls L-type calcium current (ICa,L) through its positive modulation of type-3 phosphodiesterase (PDE3). J. Cell. Physiol. 206, 329-336.
26. Marzia, M., Chiusaroli, R., Neff, L., Kim, N. Y., Chishti, A. H., Baron, R. and Horne, W. C. (2006). Calpain is required for normal osteoclast function and is down-regulated by calcitonin. J. Biol. Chem. 281, 9745-9754.
27. 2+/ calmodulin-stimulated cGMP phosphodiesterase as components of neuronal signal transduction. Adv. Second Messenger Phosphoprotein Res. 28, 111-119.
28. 2+ influx through the osteoclastic plasma membrane ryanodine receptor. Am. J. Physiol. 282, F921-F932.
29. Murthy, K. S. and Zhou, H. (2003). Selective phosphorylation of the IP3R-I in vivo by cGMP-dependent protein kinase in smooth muscle. Am. J. Physiol. 284, G221-G230.
30. Nakamura, I., Lipfert, L., Rodan, G. A. and Duong, L. T. (2001). Convergence of αvβ3 integrin- and macrophage colony stimulating factor-mediated signals on phospholipase Cγ in prefusion osteoclasts. J. Cell Biol. 152, 361-373.
31. Nomura, S. and Takano-Yamamoto, T. (2000). Molecular events caused by mechanical stress in bone. Matrix Biol. 19, 91-96.
32. O'Shaughnessy, M. C., Polak, J. M., Afzal, F., Hukkanen, M. V., Huang, P., MacIntyre, I. and Buttery, L. D. (2000). Nitric oxide mediates 17β- estradiol-stimulated human and rodent osteoblast proliferation and differentiation. Biochem. Biophys. Res. Commun. 277, 604-610.
33. Potter, D. A., Tirnauer, J. S., Janssen, R., Croall, D. E., Hughes, C. N., Fiacco, K. A., Mier, J. W., Maki, M. and Herman, I. M. (1998). Calpain regulates actin remodeling during cell spreading. J. Cell Biol. 141, 647-662.
34. Radding, W., Williams, J. P., Hardy, R. W., McDonald, J. M., Whitaker, C. H., Turbat-Herrera, E. A. and Blair, H. C. (1994). Calmodulin concentrated at the osteoclast ruffled border modulates acid secretion. J. Cell. Physiol. 160, 17-28.
35. Radding, W., Jordan, S. E., Hester, R. B. and Blair, H. C. (1999). Intracellular calcium puffs in osteoclasts. Exp. Cell Res. 253, 689-696.
36. Rooney, T. A., Joseph, S. K., Queen, C. and Thomas, A. P. (1996). Cyclic GMP induces oscillatory calcium signals in rat hepatocytes. J. Biol. Chem. 271, 19817-19825.
37. Rosser, B. G., Powers, S. P. and Gores, G. J. (1993). Calpain activity increases in hepatocytes following addition of ATP. Demonstration by a novel fluorescent approach. J. Biol. Chem. 268, 23593-23600.
38. Sanjay, A., Houghton, A., Neff, L., DiDomenico, E., Bardelay, C., Antoine, E., Levy, J., Gailit, J., Bowtell, D., Horne, W. C. et al. (2001). Cbl associates with Pyk2 and Src to regulate Src kinase activity, αvβ3 integrin-mediated signaling, cell adhesion, and osteoclast motility. J. Cell Biol. 152, 181-195.
39. Satish, L., Blair, H. C., Glading, A. and Wells, A. (2005). Interferon-inducible protein 9 (CXCL11)-induced cell motility in keratinocytes requires calcium flux-dependent activation of μ-calpain. Mol. Cell. Biol. 25, 1922-1941.
40. Sun, L., Iqbal, J., Dolgilevich, S., Yuen, T., Wu, X. B., Moonga, B. S., Adebanjo, O A., Bevis, P. J., Lund, F., Huang, C. L. et al. (2003). Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption. FASEB J. 17, 369-375.
41. Sunyer, T., Rothe, L., Jiang, X., Osdoby, P. and Collin-Osdoby, P. (1996). Proinflammatory agents, IL-8 and IL-10, upregulate inducible nitric oxide synthase expression and nitric oxide production in avian osteoclast-like cells. J. Cell. Biochem. 60, 469-483.
42. 2+, calpain and 3-phosphorylated phosphatidyl inositides; decision-making signals in neutrophils as potential targets for therapeutics. J. Pharm. Pharmacol. 56, 565-571.
43. 2+ signaling in the regulation of endothelial permeability. Vascul. Pharmacol. 39, 173-185.
44. Ueno, M., Fukuda, K., Oh, M., Asada, S., Nishizaka, F., Hara, F. and Tanaka, S. (1998). Protein kinase C modulates the synthesis of nitric oxide by osteoblasts. Calcif. Tissue Int. 63, 22-26.
45. Williams, J. P., Dong, S.-S., Whitaker, C. H., Jordan, S. E. and Blair, H. C. (1996). Effects of cell culture time and bone matrix exposure on calmodulin content and ATP-dependent cell membrane acid transport in avian osteoclasts and macrophages. J. Cell Physiol. 169, 411-419.
46. Xu, L., Eu, J. P., Meissner, G. and Stamler, J. S. (1998). Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279, 234-237.
47. Yap, C. L., Hughan, S. C., Cranmer, S. L., Nesbitt, W. S., Rooney, M. M., Giuliano, S., Kulkarni, A., Dopheide, S. M., Yuan, Y., Salem, H. H. et al. (2000). Synergistic adhesive interactions and signaling mechanisms operating between platelet glycoprotein Ib/IX and integrin αIIbβ3. Studies in human platelets ans transfected Chinese hamster ovary cells. J. Biol. Chem. 275, 41377-41388.
48. Yaroslavskly, B. B., Li, Y., Ferguson, D. J., Kalla, S. E., Oakley, J. I. and Blair, H. C. (2004). Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts. J. Cell. Biochem. 91, 962-972.
49. Yaroslavskiy, B. B., Zhang, Y., Kalla, S. E., Garcia Palacios, V., Sharrow, A. C., Li, Y., Zaidi, M., Wu, C. and Blair, H. C. (2005). NO-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP. J. Cell Sci. 118, 5479-5487.
50. Zaman, G., Pitsillides, A. A., Rawlinson, S. C., Suswillo, R. F., Mosley, J. R., Cheng, M. Z., Platts, L. A., Hukkanen, M., Polak, J. M. and Lanyon, L. E. (1999). Mechanical strain stimulates nitric oxide production by rapid activation of endothelial nitric oxide synthase in osteocytes. J. Bone Miner Res. 14, 1123-1131.